Imperium Limitless Solutions

Price: R350.00
Dosage: 1 Teaspoon a Day
Description: Immug9te is new general wellness supplement which strengthens immune system to fight the following illnesses - Hiv; High Blood Pressure; Cholesterol; Ulcers; Indigestion; Nausea; Fever; Abdominal pain; Burns; Arthritis; TB; Dermatitis; Acne; Kidney pain; Skin rash; Diuretic; Purgative; Emetic; Dizziness; Head aches; Anthrax; Wound treatment; Lupus; Warts; Cough (Twick); Food poisoning; General Malaise; Haemostatic; Rheumatism; Deworming; Malaria; Common cold; Syphilis, cystic fibrosis etc.

The supplement is a syrup and the dosage is just 5ml a day for adults and 2.5ml for children.

: People who have used Immug9te after testing positive for have recovered within 4 days.

Message us now to order yours: m.me/imperiumlimitless

Suite 304 Medstone Building
01D Umhlanga Ridge Boulevard
Umhlanga Ridge
4319

Visit and talk to us about your PPE needs and related services.

130gsm washable and 50gsm coveralls microfiber Dryvek

A test kit that provides results in a little over an hour has been created by entrepreneurs Daniel Ndima and Dineo Lioma of Cape Bio, reports Tech Financials. The pair are Allan Gray Orbis Foundation Fellows and heads of Cape Bio, a dynamic applied genomics company and spin-off of the Council for Scientific and Industrial Research.

South Africa: Entrepreneurs Pioneer Rapid COVID-19 Test Kit A COVID-19 test kit that provides results in a little over an hour has been created by entrepreneurs Daniel Ndima and Dineo Lioma of Cape Bio, reports Tech Financials. The pair are Allan Gray Orbis Foundation Fellows and heads of Cape Bio, a dynamic applied genomics company and spin-off of the Counc...

One great thing to learn from this article is that U.K. is working with their local companies in their efforts to develop a Vaccine for the and they are making real and practical progress as they are now working together about 159 companies already.

UK 'throwing everything' at coronavirus vaccine Matt Hancock says human trials for a vaccine developed by the University of Oxford will begin on Thursday.